Stockscreener 앱 받기
6.40
5.29%
0.255
전일 마감가:
$6.145
열려 있는:
$6.11
하루 거래량:
30,326
Relative Volume:
0.23
시가총액:
$2.42M
수익:
-
순이익/손실:
$-8.82M
주가수익비율:
-0.00926
EPS:
-691.4213
순현금흐름:
$-8.08M
1주 성능:
+50.47%
1개월 성능:
+82.77%
6개월 성능:
-28.18%
1년 성능:
-98.87%
1일 변동 폭
$5.8959
$6.55
1주일 범위
$4.2602
$7.50
52주 변동 폭
$2.97
$602.00
Endra Life Sciences Inc Stock (NDRA) Company Profile
명칭
Endra Life Sciences Inc
전화
734-335-0468
주소
3600 GREEN COURT, ANN ARBOR, MI
NDRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
6.33 | 2.42M | 0 | -8.82M | -8.08M | -691.42 |
|
TMO
Thermo Fisher Scientific Inc
|
423.62 | 159.05B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
198.93 | 140.21B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
479.63 | 35.17B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
109.15 | 30.47B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
153.91 | 26.47B | 15.41B | 1.37B | 2.11B | 7.50 |
Endra Life Sciences Inc 주식(NDRA)의 최신 뉴스
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Short Interest Update - The AM Reporter
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Sees Significant Growth in Short Interest - Defense World
ENDRA Life Sciences Inc (NDRA) Stock: A Year of Highs and Lows in the Market - investchronicle.com
What is ENDRA Life Sciences Inc (NDRA) Stock Return on Shareholders’ Capital? - Sete News
What Are You Thinking About Investing In ENDRA Life Sciences Inc (NASDAQ: NDRA) Stock? - Stocksregister
ENDRA Life Sciences Inc: Navigating Market Fluctuations with a 1.74M Market Cap - investchronicle.com
Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket - Benzinga
ENDRA Life Sciences Deploys TAEUS Tech to Improve Metabolic Disease Detection - Medical Product Outsourcing
A Guide To The Risks Of Investing In ENDRA Life Sciences Inc (NDRA) - knoxdaily.com
ENDRA Life Sciences (NASDAQ:NDRA) Given New $50.00 Price Target at Ascendiant Capital Markets - Defense World
NDRA stock touches 52-week low at $3.05 amid sharp annual decline By Investing.com - Investing.com South Africa
NDRA stock touches 52-week low at $3.05 amid sharp annual decline - Investing.com India
Reshape Lifesciences Stock Price, Quotes and Forecasts | NASDAQ:RSLS - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
ENDRA Life Sciences Stock Gains Market Momentum - Stocks Telegraph
ENDRA Life Sciences Advances TAEUS Liver Device Strategy - TipRanks
ENDRA Life Sciences pivots to metabolic health market - Investing.com
ENDRA Life Sciences Inc. (NDRA) reports earnings - Quartz
ENDRA Life Sciences Inc. SEC 10-K Report - TradingView
How ENDRA's AI-Powered Device Could Transform GLP-1 Weight Loss Treatment Monitoring - Stock Titan
ENDRA Slashes Monthly Expenses 37% as TAEUS Liver Device Advances - Stock Titan
ENDRA Life Sciences Inc expected to post a loss of $4.10 a shareEarnings Preview - TradingView
ENDRA Life Sciences (NDRA) Projected to Post Earnings on Thursday - Defense World
ENDRA Life Sciences Strengthens TAEUS® System Intellectual Property with Issuance of 24th U.S. Patent - Business Wire
ENDRA Life Sciences stock hits 52-week low at $3.89 amid steep decline - Investing.com Canada
ENDRA Life Sciences Announces New Clinical Study Partnership with Inselspital University Hospital in Bern, Switzerland - ACCESS Newswire
Critical Contrast: ENDRA Life Sciences (NASDAQ:NDRA) vs. Gadsden Properties (OTCMKTS:GADS) - Defense World
ENDRA Life Sciences to Participate at Upcoming Investor Conferences - ACCESS Newswire
ENDRA Life Sciences Strengthens Global Intellectual Property Protection with Issuance of Two European Patents Related to its TAEUS Probe - ACCESS Newswire
ENDRA Life Sciences Issued Chinese Patent for Its TAEUS(R) Platform Technology to Calculate Fat Concentration in Tissue - ACCESS Newswire
Where are the Opportunities in (NDRA) - Stock Traders Daily
What Makes ENDRA Life Sciences (NDRA) a New Strong Buy Stock - MSN
Financial Contrast: NeurAxis (NASDAQ:NRXS) versus ENDRA Life Sciences (NASDAQ:NDRA) - Defense World
(NDRA) On The My Stocks Page - Stock Traders Daily
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.36% - MSN
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.14% - MSN
(NDRA) Trading Signals - Stock Traders Daily
Study Highlighting ENDRA Life Sciences TAEUS Technology in Patients with High BMI to be presented at AASLD's The Liver Meeting 2024 - Marketscreener.com
Data I/O And 2 Other Stocks Under $5 Executives Are Buying - MSN
Nexalin Technology (NASDAQ:NXL) and ENDRA Life Sciences (NASDAQ:NDRA) Head-To-Head Survey - Defense World
(NDRA) Technical Data - Stock Traders Daily
ENDRA Life Sciences Inc trading halted, volatility trading pause - TipRanks
ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement - Defense World
ENDRA Life Sciences meets Nasdaq listing standards By Investing.com - Investing.com Australia
ENDRA Life Sciences meets Nasdaq listing standards - Investing.com
Endra Life Sciences regains compliance with Nasdaq - TipRanks
ENDRA Life Sciences Regains Nasdaq Compliance, Clears Path for Strategic Growth | NDRA Stock News - StockTitan
ENDRA Life Sciences Reports Q3 2024 Results and Progress - TipRanks
Post Holdings beats Q4 estimates, issues fiscal 2025 outlook - Investing.com
ENDRA Life Sciences Cuts Operating Costs 52%, Accelerates Clinical Trial Progress | NDRA Stock News - StockTitan
ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update - Business Wire
Endra Life Sciences Inc (NDRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.15%
자본화:
|
볼륨(24시간):